BioSpace News Archive

Business

1 in 4 medical cannabis users say it’s now harder to access cannabis since recreational legalization

The legalization of recreational cannabis in Canada has had an impact on access to medical cannabis, with one in four medical cannabis users saying that it is now harder to access the cannabis they need.

July 4, 2019
·
5 min read
Policy

Information Update - Infrared saunas not authorized to treat any medical conditions

Health Canada is advising Canadians that infrared saunas are not authorized in Canada to treat any medical conditions, including high blood pressure, diabetes or autism.

July 4, 2019
·
1 min read
FDA

Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies

The company plans to launch Xembify® in the United States in the last quarter of the year and is working to obtain additional approvals in Canada, Europe and other global markets

July 4, 2019
·
8 min read
Kleresca® Strengthens Scientific Proof of Fluorescent Light Energy (FLE) in New Study

In a recent, peer-reviewed study, Kleresca® presents documentation that its unique FLE technology is able to reduce inflammation in the skin, enhance collagen production, and encourage the development of new blood vessels.

July 4, 2019
·
1 min read
BioInvent Receives Milestone Payment Related to TAK-169 Investigational New Drug Application

The antibody used in TAK-169 was discovered using BioInvent’s n-CoDeR® antibody library

July 4, 2019
·
2 min read
Business

Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of €1.25 Million Following First Commercial Sale of Pliaglis by Cantabria in Italy

Crescita Therapeutics Inc. announced that it has received the second instalment of € $1.25 million of the up-front payment related to the out-licensing of Pliaglis in Italy, France, Spain and Portugal, from its partner, Cantabria Labs.

July 4, 2019
·
5 min read
Drug Development

NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study

NeuroVive Pharmaceutical AB announced that the company has initiated the second part in its ongoing Phase Ia/b clinical study with KL1333, NeuroVive’s candidate drug for chronic treatment of genetic mitochondrial diseases, following successful completion of the first part.

July 4, 2019
·
4 min read
BioMidwest

HIPAA-Compliant Geospatial Health Analytics - Now Available for Tableau

Spatialitics, the leader in enterprise geospatial SaaS applications, and Integeo, a location intelligence company, have come together to offer a fully secure, HIPAA-Compliant Cloud Geocoding solution for Tableau users in healthcare.

July 4, 2019
·
2 min read
European Society of Cardiology Hosting Cutting-edge Digital Summit

A major medical society is tackling the opportunities and challenges of digital health

July 4, 2019
·
3 min read
Business

Dr. Peter Centre’s Innovative Program for Men Over 50 Living With HIV Sees Enrolment Double

The Dr. Peter Centre, a non-profit organization that supports innovative healthcare delivery in the Metro Vancouver area for people living with HIV, has seen major uptake for its unique Evening Program pilot project since launching in 2017.

July 4, 2019
·
2 min read